Endocrine Abstracts

CA19-9 (sialyl Lewis[a] antigen) was originally described as a gastrointestinal system and pancreas specific tumour marker. Immunohistochemical studies have demonstrated that CA19-9 is expressed in both differentiated and anaplastic thyroid carcinomas. Increased serum levels of CA 19-9 were reported in few patients with anaplastic thyroid cancer; however, to the best of our knowledge, there is no previous report about serum levels of CA 19-9 in differentiated thyroid cancer. S...

BackgroundThe latest WHO classification of tumours of endocrine organs defines new units of borderline thyroid tumours (BTT) of uncertain biological behaviour. The aim of our study was to evaluate ultrasonographic, cytological features, mutation profile and surgery treatment in patients with these rare tumours.MethodsThe analysis of 8 out of 487 operated patients, who underwent thyroid surgery between June 20...